• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    SPI Pharma has been solving formulation challenges using superior functional materials.
    All News #Library
    Biotech

    FDA Investigates Patient Deaths with Sarepta`s Gene Therapy

    FDA

    Royalty to pay up to $2B to Revolution Medicines For Cancer Drug

    GLOBENEWSWIRE

    Capricor Says FDA May Not Convene Panel for Co`s Cell Therapy

    REUTERS

    US CDC Vaccine Presentation Cites Study that Does Not Exist

    REUTERS

    Biocon Biologics Partners with National Cancer Society Malaysia

    INDPHARMAPOST

    Glenmark Launches Tevimbra in India for Lung, Esophageal Cancer

    EXPRESSPHARMA

    Utopia Therapeutics gets $1.5M seed funding from whale tank

    EXPRESSPHARMA

    Aspire Doses Last Patient in Ph 1 Trial of Oral High-Dose Aspirin

    ACCESSWIRE

    CureVac Announces Voting Results of General Meeting

    ACCESSWIRE

    Longeveron® Completes Enrollment of Laromestrocel Trial for HLHS

    GLOBENEWSWIRE

    Krystal Doses First Patient in Ph 3 KB803 Cornea Study

    GLOBENEWSWIRE

    Iridex Enrolls First Patient in UK Study on MicroPulse® Tech

    GLOBENEWSWIRE

    Lexeo PXV venBio Partner on Cardiac RNA Therapeutics

    GLOBENEWSWIRE

    BriaCell Gets DSMB Green Light for Ph 3 Breast Cancer Trial

    GLOBENEWSWIRE

    Radiopharm and Cyclotek Ink Deal for 161Tb KLK3 Ph 1 Trial

    GLOBENEWSWIRE

    Starton and Bend Partner on Oral STAR-LLD Lenalidomide Form

    GLOBENEWSWIRE

    Novoheart Joins Project on Mini-Hearts for HLHS Treatment

    GLOBENEWSWIRE

    Clearmind Teams with Political Firm to Back Psychedelics

    GLOBENEWSWIRE

    CytoDyn Starts Phase II Trial in Colorectal Cancer

    GLOBENEWSWIRE

    Enobosarm Cuts Weight Regain Post Semaglutide in Ph 2b Trial

    GLOBENEWSWIRE

    THC Therapeutics Acquires Cannabis Firms in OR and CA

    GLOBENEWSWIRE

    Ernexa Therapeutics Secures $6M in Second Closing of Agreement

    GLOBENEWSWIRE

    Senti Bio to Present at 2025 SEED Conference

    GLOBENEWSWIRE

    Priothera secures €1.7M i-Nov funding from Bpifrance

    GLOBENEWSWIRE

    Ono Pharma & Vertex to Develop Povetacicept in Japan, South Korea

    BUSINESSWIRE

    Sarclisa Recommended for EU Approval by CHMP for Myeloma

    PRESS RELEASE

    Sanofi Signs €545M Deal to Explore Formation’s JAK/SYK Inhibitor

    PR NEWSWIRE

    Roche’s Bispecific-ADC Combo keeps Lymphoma at Bay

    FIERCE PHARMA

    Ex-Anti-Vax Leader to Speak at CDC Vaccine Panel

    REUTERS

    Imaavy (nipocalimab-aahu) outperforms FcRn blockers in gMG

    PR NEWSWIRE

    Amgen`s Phase 2 obesity study of monthly Maritide results at ADA

    PR NEWSWIRE

    BrightGene Reports Positive Ph2 Data for Dual GLP-1/GIP Agonist

    PR NEWSWIRE

    Merck`s WINREVAIR™ Met Primary Endpoint in PAH Study

    BUSINESSWIRE

    Fujirebio Acquires PSG to Boost Life Science Capabilities

    BUSINESSWIRE

    United Therapeutics Concludes Ralinepag ADVANCE Trial

    BUSINESSWIRE

    OpRegen® (RG6501) 36-Month Visual Acuity Results at Summit 2025

    BUSINESSWIRE

    Arrowhead Completes Enrollment in Three Plozasiran Trials

    BUSINESSWIRE

    Eddie Gray joins Botanical Solution Board of Directors

    BUSINESSWIRE

    Qlaris Bio to Present Data on QLS-111 at 2025 Glaucoma Congress

    BUSINESSWIRE

    Laekna Presents Studies Results of LAE102, LAE103, and LAE123

    BUSINESSWIRE

    Galatea Bio, Fabric Genomics Partner for Genetic Testing

    BUSINESSWIRE

    GeneDx: AAP Recommends Exome, Genome Sequencing for GDD

    BUSINESSWIRE

    Datroway approved in US as first TROP2 Therapy for Lung Cancer

    BUSINESSWIRE

    Axcelead, Superluminal to Collaborate on Drug Discovery

    BUSINESSWIRE

    Harbour BioMed, Otsuka Partner to Advance BCMAxCD3 T-Cell Engager

    PR NEWSWIRE

    Vertex`s Diabetes Therapy Allows 10 Patients to Come Off Insulin

    ENDPNTS

    Exelixis: Zanzalintinib Combo Boosts OS in Colorectal Cancer

    BUSINESSWIRE

    Prime Success Welcomes NY Ruling on Sinovac Shareholder Vote

    BUSINESSWIRE

    Biocon concludes a Rs 4,500 crore equity fundraise through QIP

    INDPHARMAPOST

    Tweaked ACIP vaccine agenda raises industry watcher concerns

    FIERCE PHARMA

    Arialys Presents Promising Data for IgG1 Antibody Treatment

    FIERCE BIOTECH

    Roche Combo Lunsumio & Polivy Doubles Remission in LBCL

    PRESS RELEASE

    Ferring Opens New Gene Therapy Manufacturing Facility

    CONTRACTPHARMA

    Candid Moves T-Cell Engagers Into Autoimmune Trials

    BUSINESSWIRE

    FDA Reviewing Opzelura Cream for Kids With Dermatitis

    BUSINESSWIRE

    Sinovac Board Wins Against Advantech/Prime in New York Lawsuit

    BUSINESSWIRE

    NurExone Joins ARMI HealthTech Hub Accelerator, Updates Strategy

    GLOBENEWSWIRE

    CHMP Backs Darzalex for High-Risk Smouldering Myeloma

    GLOBENEWSWIRE

    Aptose and Hanmi`s New Loan Agreement for Tuspetinib in AML

    GLOBENEWSWIRE

    Actuate Shares Phase 2 Pancreatic Cancer Trial Data

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.